Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Epilepsia|February 9, 2017
What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new-onset epilepsy?Roy C Martin, Edward Faught, Jerzy P Szaflarski, et al.Medical Care|July 12, 2012
Diagnostic tests and neurology care for Medicare beneficiaries with seizures: differences across racial groupsMaria Pisu, Joshua S Richman, Roy C Martin, et al.Journal of Alzheimer'S Disease : JAD|May 1, 2023
Specialist Availability and Drug Adherence in Older Adults with Dementia Across Regions of the United StatesGiovanna Pilonieta, Maria Pisu, Roy C Martin, et al.Epilepsia|February 8, 2018
Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with riskEdward Faught, Jerzy P Szaflarski, Joshua Richman, et al.Parkinsonism & Related Disorders|December 6, 2018
Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disordersAdam Gerstenecker, Lacey Grimsley, Brittney Otruba, et al.Epilepsia|September 11, 2012
Geographic variation of epilepsy for older Americans: how close to the geographic variation of stroke?Maria Pisu, Polly Kratt, Edward Faught, et al.Epilepsy & Behavior : E&B|April 17, 2017
Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderlyJerzy P Szaflarski, Roy C Martin, Edward Faught, et al.Clinical Gerontologist|April 29, 2017
Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive ImpairmentLindsay M Niccolai, Kristen L Triebel, Adam Gerstenecker, et al.Epilepsy & Behavior : E&B|September 2, 2020
Effects of highly purified cannabidiol (CBD) on fMRI of working memory in treatment-resistant epilepsyTyler E Gaston, Jane B Allendorfer, Sangeeta Nair, et al.Epilepsy & Behavior : E&B|August 8, 2020
Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsyMatthew D Thompson, Roy C Martin, Leslie P Grayson, et al.Pageof 8